These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6499297)

  • 21. Quantitative analysis of axon collaterals of single superficial pyramidal cells in layer IIb of the piriform cortex of the guinea pig.
    ul Quraish A; Yang J; Murakami K; Oda S; Takayanagi M; Kimura A; Kakuta S; Kishi K
    Brain Res; 2004 Nov; 1026(1):84-94. PubMed ID: 15476700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mortalin: a protein associated with progression of Parkinson disease?
    Shi M; Jin J; Wang Y; Beyer RP; Kitsou E; Albin RL; Gearing M; Pan C; Zhang J
    J Neuropathol Exp Neurol; 2008 Feb; 67(2):117-24. PubMed ID: 18219256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dementia in diffuse cortical Lewy body disease].
    Plas J; Dubrugeaud G; Jeanneau A; Brion S
    Encephale; 1993; 19(5):541-5. PubMed ID: 8306922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relation between lipofuscin content and organelle density in pyramidal cells of laminae III and V of area 10 (Brodmann) of the cerebral frontal lobe of humans of different ages].
    Rösler B; Kemnitz P
    J Hirnforsch; 1983; 24(4):415-24. PubMed ID: 6643994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid beta-peptide and the dementia of Parkinson's disease.
    Jendroska K; Lees AJ; Poewe W; Daniel SE
    Mov Disord; 1996 Nov; 11(6):647-53. PubMed ID: 8914090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortical Lewy bodies in Alzheimer's disease.
    Kazee AM; Han LY
    Arch Pathol Lab Med; 1995 May; 119(5):448-53. PubMed ID: 7748074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neocortical changes in Parkinson's disease, revisited.
    Sugiyama H; Hainfellner JA; Yoshimura M; Budka H
    Clin Neuropathol; 1994; 13(2):55-9. PubMed ID: 8205726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes of functional connectivity of the motor network in the resting state in Parkinson's disease.
    Wu T; Wang L; Chen Y; Zhao C; Li K; Chan P
    Neurosci Lett; 2009 Aug; 460(1):6-10. PubMed ID: 19463891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of a breakdown of corticostriatal connections in Parkinson's disease.
    Stephens B; Mueller AJ; Shering AF; Hood SH; Taggart P; Arbuthnott GW; Bell JE; Kilford L; Kingsbury AE; Daniel SE; Ingham CA
    Neuroscience; 2005; 132(3):741-54. PubMed ID: 15837135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease.
    Cordato NJ; Halliday GM; Harding AJ; Hely MA; Morris JG
    Ann Neurol; 2000 Jun; 47(6):718-28. PubMed ID: 10852537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On pigment-loaded stellate cells within layer II and III of the human isocortex.
    Braak H
    Cell Tissue Res; 1974; 155(1):91-104. PubMed ID: 4141284
    [No Abstract]   [Full Text] [Related]  

  • 33. Focal changes of oxygen consumption in cerebral cortex of patients with Parkinson's disease during subthalamic stimulation.
    Vafaee MS; ØStergaard K; Sunde N; Gjedde A; Dupont E; Cumming P
    Neuroimage; 2004 Jun; 22(2):966-74. PubMed ID: 15193628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropathological study on the nucleus basalis of Meynert in mature and old age.
    Szenborn M
    Patol Pol; 1993; 44(4):211-6. PubMed ID: 8309732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinico-pathomorphologic correlations in parkinsonism].
    Starikov AS; Obraztsova RG; Kleĭn AV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(12):28-32. PubMed ID: 6762023
    [No Abstract]   [Full Text] [Related]  

  • 36. Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability.
    Pieper HC; Evert BO; Kaut O; Riederer PF; Waha A; Wüllner U
    Neurobiol Dis; 2008 Dec; 32(3):521-7. PubMed ID: 18930140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of cortical degeneration in Parkinson disease.
    Shulman JM; Schneider JA
    Neurology; 2012 Oct; 79(17):1750-1. PubMed ID: 23019261
    [No Abstract]   [Full Text] [Related]  

  • 38. The deposition of aging pigment in the human cerebral cortex.
    BRODY H
    J Gerontol; 1960 Jul; 15():258-61. PubMed ID: 13804666
    [No Abstract]   [Full Text] [Related]  

  • 39. Cerebral changes associated with senility. I. The role of transneuronal degeneration in the neocortex.
    Escobar A
    Bol Estud Med Biol; 1973 Jan; 28(1):1-8. PubMed ID: 4804954
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study of involutive changes of the cerebellar cortex in senility].
    Boya J; Zamorano L; Calvo J
    Arch Neurobiol (Madr); 1974 May; 37(3):251-70. PubMed ID: 4858220
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.